Director/PDMR Shareholding

RNS Number : 0751F
Rentokil Initial PLC
24 October 2018
 

Rentokil Initial plc (the "Company")

24 October 2018

 

Notification of transactions by persons discharging managerial responsibilities

 

The Company hereby announces that Jürgen Höfling has today exercised 100,000 shares of his award granted under the Rentokil Initial plc Performance Share Plan (PSP) in March 2015. The 100,000 ordinary shares in the Company were sold at a price of 289p per share.

 

The relevant notification set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Jürgen Höfling

2

 

Reason for the notification

 

a)

 

Position/status

 

Regional Managing Director, Europe (PDMR)

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

b)

 

Nature of the transaction

 

Exercise and sale of award made under the 2015 Performance Share Plan (PSP)

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£2.89

100,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

100,000

 

£289,000

e)

 

Date of the transaction

 

24 October 2018

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Enquiries:

 

Daragh Fagan, Company Secretary              Rentokil Initial plc             01276 607444


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBXBDGXXDBGIS
UK 100